Where is the frozen food road after the "bonus period
Time of Update: 2022-09-04
As a leading enterprise in the field of quick-frozen rice and noodle products, Sanquan Foods recently disclosed its 2021 annual report, showing that during the reporting period, the company's net profit attributable to shareholders of listed companies was 641 million yuan, a year-on-year decrease of 16.
Although the road for Chinese innovative drugs to go overseas is difficult, there are also new expectations
Time of Update: 2022-04-18
The industry believes that the acceptance of this model by European companies means that the clinical and market value of the product has been recognized, which will help to accelerate the internationalization of Yifan Pharmaceuticals, and also provide some confidence and expectations for China's innovative drugs to go overseas .
This innovative drug company with a rich R&D pipeline has received more than 600 million yuan in financing
Time of Update: 2022-01-08
According to data, Xuanzhu Biotechnology was established in 2002, and it is one of the few domestic platform-based innovative drug companies capable of independent research and development in the fields of small molecules and macromolecules at the same time .
AbbVie Humira biosimilars are expected to be approved
Time of Update: 2021-02-21
Humira is used to treat rheumatoid arthritis and other inflammatory diseases, and last year sales of the drug were close to $15 billion, according to Ames Medical.
the FDA only last year approved the first biosimilar, the Axon Neupogen generic developed by Novarlor.
Star Lake Technology: 2014 Annual Results Pre-Loss Announcement
Time of Update: 2020-06-30
Xinghu Technology (600866) announced on January 23, by guangdong Zhaoqing Xinghu Biotech Co., Ltd financial department preliminary estimates, the 2014 operating results are expected to be a loss, to
Intermune's IPF drug follows bringer's "breakthrough" certification by FDA
Time of Update: 2014-07-21
Source: on July 21, 2014, a drug being developed by dingxiangyuan company for the treatment of rare lung diseases was recognized by FDA as a breakthrough therapy It was tied with bringer Ingelheim, an